Home » Topics » Regulatory » Patents

Patents
RSS

Wuhan LL Science and Technology Development presents new ROCK inhibitors

Feb. 8, 2022

Chiesi Farmaceutici identifies new TGFBR1 inhibitors for IPF

Feb. 8, 2022

Beijing Tide Pharmaceutical synthesizes new ATR kinase inhibitors

Feb. 8, 2022

Researchers divulge SSTR4 agonists for treatment of pain

Feb. 8, 2022

Roche patents new TLR antagonists for autoimmune disease

Feb. 8, 2022

Bristol Myers Squibb presents new FPR agonists

Feb. 7, 2022

Klotho Therapeutics synthesizes novel compounds for hypertension

Feb. 7, 2022

VelosBio identifies new anti-ROR1 ADCs

Feb. 7, 2022

Aligos Therapeutics discloses new THR agonists

Feb. 7, 2022

Tactogen patents 5-HT1B receptor agonists and MAO-A inhibitors

Feb. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...